Bioinvent International Ab
Clinical trials sponsored by Bioinvent International Ab, explained in plain language.
-
First human test for experimental cancer antibody begins
Disease control OngoingThis is a first-in-human trial testing a new drug called BI-1910, both alone and combined with an existing immunotherapy (pembrolizumab), for people with advanced solid tumors that have worsened after standard treatments. The main goals are to find a safe dose, check for side eff…
Phase: PHASE1, PHASE2 • Sponsor: BioInvent International AB • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
New hope for Tough-to-Treat skin cancer: experimental combo targets immune system
Disease control OngoingThis early-stage trial is testing a new three-drug combination for people with advanced melanoma that has spread or cannot be removed by surgery and has worsened after standard immunotherapy. The study aims to find a safe and effective dose of the experimental drug BI-1607 when g…
Phase: PHASE1, PHASE2 • Sponsor: BioInvent International AB • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC